期刊文献+

乳腺浸润性导管癌超声声像与分子免疫学指标检测相关性探讨 被引量:2

Relation between the sonograpic features of IDC and immunohistochemistical factors
暂未订购
导出
摘要 目的探讨乳腺浸润性导管癌(IDC)超声声像与分子免疫学指标——雌激素受体(ER)、孕激素受体(PR)、人类上皮生长因子受体(CerbB-2)表达水平的关系。方法回顾性总结98例IDC超声图像特征,并与经超声引导下自动活检(USGAB)术穿刺活检分子免疫组化结果ER、PR、CerbB-2表达行相关性分析。结果ER、PR、CerbB-2分组结果显示:肿瘤边缘毛刺征组ER表达阳性率明显高于无边缘毛刺征组,差异有统计学意义(P<0.01);肿瘤微钙化组PR表达阳性率明显高于无微钙化组,差异有统计学意义(P<0.01);周边高回声晕组及边缘毛刺征组PR表达阳性率高于周边无高回声晕组及无边缘毛刺征组,差异有统计学意义(P<0.05);肿瘤微钙化组、腋窝肿大淋巴结组CerbB-2表达阳性率明显高于肿瘤内无微钙化组、腋窝无肿大淋巴结组,差异有统计学意义(P<0.01)。结论IDC超声声像特征与ER、PR、CerbB-2表达水平有一定相关性,部分超声征象可能对其生物学特性有提示和评估的意义。 Objective To observe the relationship between sonographic features of IDC and immunohisto- chemistical factors (ER, PR, cerbB-2). Methods Retrospectively reviewed the sonographie features of IDC in 98 patients, analyzed correlation relationship between sonographic features detected by USGAB and the posi- tive rate of ER, PR and cerbB-2 determined by immunohistochemistical technique. Results Positive rate of ER with spicular signs was significantly higher than without lesions ( P 〈 0.01 ) ; PR with mierocaleificatations was significantly higher than without lesions ( P 〈 0.01 ) ; PR with surrounding hyperechoic halo and spicular signs was significantly higher than without lesions ( P 〈 0.05 ) ; cerbB-2 with microcalcificatations and lymph- adenectasis in axillary were significantly higher than without lesions (P 〈 0.01 ). Conclusions The sonograph- ic features of IDC has correlation to the expression of ER. PR and cerbB-2.
出处 《中国肿瘤外科杂志》 CAS 2010年第3期142-145,共4页 Chinese Journal of Surgical Oncology
基金 江苏省科技厅自然科学基金项目(BK2009447)
关键词 浸润性导管癌 超声声像特征 分子免疫学指标 IDC sonographic features immunohistochemistical factors
  • 相关文献

参考文献8

  • 1Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J].J Clin Oncol,2007,25(33):5287-5312.
  • 2Baqai T,Shousha S.Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast[J].Histopathology,2003,42(5):440-447.
  • 3谭旭艳,吴丹,高志刚,张婷.超声引导自动活检术在乳腺癌术前病理诊断的价值[J].江苏医药,2009,35(1):12-13. 被引量:9
  • 4何敬海,秦玲,陈东风,刘阿庆,安霞,王少春,曹长军,韩友东.乳腺浸润性导管癌的超声诊断特征[J].济宁医学院学报,2006,29(4):23-24. 被引量:2
  • 5Paradiso A,Mangia A,Barlentta A,et al.Mammography and morphobiologic characteristics of human breast cancer[J].Tumori,1993,79(6):422-426.
  • 6Thurfjell MG,Lindgren A,Thurfjell E.Nonpalpable breast cancer:mammographic appearance as predictor of histologic type[J].Radiology,2002,222(1):165-170.
  • 7Ross JS,Fletcher JA,Linette GP,et al.The Her-2/neu gene and protein in breast cancer 2003:biomarker and target of therapy[J].Oncologist,2003,8(4):307-325.
  • 8Osborne CK,Yochmowitz MG,Knight WA 3rd,et al.The value of estrogen and progesterone receptors in the treatment of breast cancer[J].Cancer,1980,46(12 Suppl):2884-2888.

二级参考文献15

  • 1江泽飞,徐兵河,宋三泰,孙燕.乳腺癌内分泌治疗的基本共识[J].中华肿瘤杂志,2006,28(3):238-239. 被引量:49
  • 2Coates AS, Keshaviah A, Thurlimann B, et al. Five years of letrozole eompared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast eaneer: update of study BIG1-98 [J]. J Clin Oneol, 2007,25(5) :486-492.
  • 3Jordan VC. Tamoxifen: a most unlikely pioneering medicine [J]. Nat Rev Drug Diseov,2003,2(3):205-213.
  • 4Badoual A, Maruanic C, Ghorra, et al. Pathological prognos tic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions[J]. The Breast, 2005,14 (1) : 22-27.
  • 5Baqai T, Shousha S. Oestrogen receptor negativity as a marker for highgrade ductal carcinoma in situ of the breast[J]. Histopathology, 2003,42(5) : 440-447.
  • 6Stavros AT,Thicknan D,Rapp CV,et al.Solid breast nodules:use of sonographyto distinguish between benign and malignant lesions.Radiology,1995,196(1):123
  • 7Seidman MD,Lauren LA,Aisner SC,et al.Relationship of the size of the invasive component of the primary breast carcimoma to axillary lymph mode metastasis.Cancer,1995,75 (1):65
  • 8Tavassoli FA.Pathology of advanced primary breast carconoma.Surg Oncol Clin N Am,1995,4(4):591
  • 9Skaane P,Engedal K.Analysis of sonographic features in the differentiation of fibrodenoma and invsive ductal carcinoma.AJR,1998,170(1):109
  • 10Wright IA,Pugh ND,Lyons K,et al.Power doppler in breast tumors:a comparison with conventional colour Doppler imaging.Eur J Ultrasound,1998,7(3):175

共引文献9

同被引文献26

  • 1Kurosumi M.Significance of histopathological evaluation in primary therapy for breast cancer--recent trends in primary modality with pathological complete response(pCR) as endpoint[J].Breast Cancer,2004,11(2):139-147.
  • 2Ogston KN,Miller ID,Payne S,et al.A new histological grading system to assess response of breast cancers to primary chemotherapy:prognostic significance and survival[J].Breast,2003,12(5):320-327.
  • 3Abrial C,Van Praagh I,Delva R,et al.Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine,epirubicin,and paclitaxel as neoadjuvant treatment in patients with operable breast cancer[J].Oncologist,2005,10(4):242-249.
  • 4Christopher A,Garces MD,William G,et al.Neoadjuvant chemotherapy of breast cancer[J].Am Surg,2004,70(7):565-568.
  • 5Roubidoux MA,LeCarpentier GL,Fowlkes JB,et al.Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy[J].J Ultrasound Med,2005,24(7):885-895.
  • 6Kuerer HM,Newman LA,Buzdar AU,et al.Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer[J].Am J Surg,1998,176(6):502-509.
  • 7Huber S,Medl M,Helbich T,et al.Locally advanced breast carcinoma:computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy(work in progress)[J].J Ultrasound Med,2000,19(9):601-607.
  • 8Yang WT,Tse GM.Sonographic,mammographic,and histopathologic correlation of symptomatic ductal carcinoma in situ[J].AJR,2004,182(1):101-110.
  • 9Yang WT,Dryden M,Broglio K,et al.Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women[J].Breast Cancer Res Treat,2008,111(3):405-410.
  • 10Wang Y,Ikeda DM,Narasimhan B,et al.Estrogen receptor-negative invasive breast cancer:imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression[J].Radiology,2008,246 (2):367-375.

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部